Bhumyamalaki for Fatty Liver: Evidence & Safety

Bhumyamalaki for fatty liver is a topic attracting growing interest as people seek complementary approaches to liver health. Bhumyamalaki, derived from Phyllanthus niruri or Phyllanthus amarus, is a traditional Ayurvedic herb historically used to support liver function. With fatty liver disease now affecting a significant proportion of the UK population, understanding what the evidence actually says about herbal remedies is important. This article examines the science behind bhumyamalaki, what UK clinical guidance recommends for fatty liver management, and what to discuss with your GP before trying any herbal supplement.

What is bhumyamalaki and how is it used in herbal medicine?

Bhumyamalaki is a traditional Ayurvedic herb from the Phyllanthus genus, used historically for liver and urinary conditions. In the UK it is sold as an unregulated food supplement, not a licensed medicine.

Bhumyamalaki is a common name applied to several small tropical herbs in the Phyllanthus genus, most often Phyllanthus niruri or Phyllanthus amarus. These are related but distinct species, and the composition of bioactive compounds can vary between them. The plants are native to tropical and subtropical regions and have been documented in traditional Indian, South American and African healing systems. The Sanskrit name translates loosely as 'earth gooseberry', reflecting the plant's low-growing habit and small, berry-like fruits.

In Ayurvedic practice, bhumyamalaki is classified as a 'hepatoprotective' herb, meaning it is traditionally believed to protect and support liver function. Practitioners have historically used preparations made from the whole plant, including leaves, stems and roots, in the form of powders, decoctions or standardised extracts. Traditional contexts of use have included jaundice, hepatitis, kidney stones and urinary tract complaints, as documented in sources such as WHO monographs on selected medicinal plants.^[1]

The herb contains a range of bioactive compounds, including phyllanthin, hypophyllanthin, lignans, flavonoids and tannins.^[1] Laboratory studies have suggested that some of these compounds may have antioxidant, anti-inflammatory and antifibrotic properties, which has generated scientific interest in its potential role in liver disease. However, traditional use does not constitute clinical evidence of efficacy or safety.

In the UK, most Phyllanthus products are sold as food supplements rather than as licensed medicines. A small number of herbal medicines may hold an MHRA Traditional Herbal Registration (THR), which requires evidence of quality and traditional use but not clinical proof of efficacy.^[5][6] Most Phyllanthus products on the UK market are unlikely to hold a THR and are therefore not subject to the same regulatory scrutiny as medicines authorised by the MHRA. When purchasing any herbal supplement, choose products from reputable UK suppliers and be aware that quality, purity and the quantity of active compounds can vary considerably between products; some have been found to contain contaminants or undisclosed ingredients, as highlighted in MHRA advisories on herbal product safety.^[9]

If you develop symptoms that could suggest liver injury, such as jaundice, dark urine, severe fatigue or itching, stop taking the supplement and seek medical advice promptly.

What does the current evidence say about liver health benefits?

Current clinical evidence for bhumyamalaki in liver disease is limited, low quality and inconclusive. No UK regulatory body or NICE guideline endorses its use for fatty liver disease.

The current clinical evidence for bhumyamalaki in liver disease, including fatty liver, remains limited and inconclusive, and no UK regulatory body has endorsed its use for this purpose. Most of the available research consists of small-scale laboratory studies, animal experiments and a modest number of human clinical trials, many of which have methodological limitations such as small sample sizes, short follow-up periods and lack of placebo controls.

Some preclinical studies have demonstrated that Phyllanthus extracts can reduce markers of liver inflammation and oxidative stress in animal models of liver injury. A Cochrane systematic review examining Phyllanthus species for chronic hepatitis B found that while some trials reported reductions in liver enzyme levels (alanine aminotransferase and aspartate aminotransferase), the overall evidence was of low quality and findings were inconsistent across trials.^[4] These trials were not designed to evaluate fatty liver disease.

Fatty liver disease is now more precisely termed metabolic dysfunction-associated steatotic liver disease (MASLD) in updated international nomenclature, and this terminology is increasingly reflected in UK clinical literature, including NHS resources on fatty liver disease.^[7][8] There is currently no robust, peer-reviewed evidence from large randomised controlled trials demonstrating that bhumyamalaki safely and effectively reduces liver fat, improves liver histology or prevents disease progression in people with MASLD. NICE has not issued guidance on the use of bhumyamalaki or any Phyllanthus species for liver conditions, and it does not feature in NHS clinical pathways for MASLD management, which focus on lifestyle modification and management of metabolic risk factors.^[2][3] Researchers continue to investigate herbal compounds with hepatoprotective potential, but at present the evidence base is insufficient to support clinical recommendations.

What should you discuss with your GP before trying herbal remedies?

Speak to your GP before starting bhumyamalaki, particularly if you take prescribed medicines, as it may interact with anticoagulants, antidiabetics and antihypertensives and can affect liver enzyme results.

Before starting any herbal remedy, including bhumyamalaki, you should speak to your GP, particularly if you have a diagnosed liver condition, take prescribed medicines or have other underlying health conditions. This conversation is important because herbal supplements can interact with prescribed medications, affect liver enzyme levels and, in some cases, cause direct liver injury, a phenomenon known as herb-induced liver injury (HILI).

Key points to raise with your GP include:

• Current medications: Bhumyamalaki may interact with anticoagulants, antidiabetic drugs and antihypertensive medicines. Some Phyllanthus species have been shown in laboratory studies to inhibit certain liver enzymes involved in drug metabolism, which could theoretically alter the effectiveness or safety of prescribed treatments.^[11] The clinical significance of these interactions in humans is not well established, and you should discuss any concerns with your GP or pharmacist, who can consult recognised interaction resources.

• Liver function tests: If you have fatty liver disease, your GP may already be monitoring your liver enzymes. Starting a herbal supplement without informing your doctor could complicate the interpretation of these results. If your clinician agrees it is appropriate to try a supplement, ask about baseline and follow-up liver function testing, and stop taking the product and seek advice if your results worsen or you develop new symptoms.

• Supplement quality and regulation: In the UK, herbal supplements sold as food products are not required to demonstrate efficacy before sale. Quality, purity and the dose of active compounds can vary considerably between products.

• Pregnancy, breastfeeding and children: There is insufficient safety data on bhumyamalaki in pregnancy or breastfeeding, and its use is generally not recommended during these periods. Children and people with known liver disease or advanced liver fibrosis should not start herbal supplements without specialist advice.

• When to stop and seek help: If you experience symptoms that could suggest liver injury, such as jaundice, dark urine, severe fatigue or itching, stop the supplement immediately and contact your GP.

Your GP can help you weigh the potential risks and benefits in the context of your individual health, and can refer you to a hepatologist or dietitian if specialist input is needed for managing fatty liver disease.

If you suspect you have experienced a side effect from a herbal supplement, you can report it to the MHRA via the Yellow Card Scheme at yellowcard.^[12][13]mhra.gov.uk.

Can bhumyamalaki actually help with fatty liver disease?

There is no established clinical proof that bhumyamalaki treats or reverses fatty liver disease. NICE-recommended management focuses on lifestyle modification and metabolic risk factor control.

Based on the available evidence, there is no established clinical proof that bhumyamalaki can treat or reverse fatty liver disease in humans, and it should not be used as a substitute for evidence-based management. Metabolic dysfunction-associated steatotic liver disease (MASLD) is primarily managed through lifestyle modification, including sustained weight loss, a balanced diet, increased physical activity and optimisation of metabolic risk factors such as type 2 diabetes, hypertension and dyslipidaemia. NICE guidance on non-alcoholic fatty liver disease (NICE NG49) supports these approaches as the cornerstone of management, and the NHS fatty liver disease pages reflect the same priorities.^[2][10]

In UK primary care, assessment of suspected MASLD typically includes liver function tests and calculation of a fibrosis score such as FIB-4, which uses age, liver enzyme levels and platelet count to estimate the risk of significant liver fibrosis.^[2][10] People with a higher FIB-4 score or other indicators of advanced disease may be referred for further assessment, such as enhanced liver fibrosis (ELF) testing or transient elastography, and onward referral to hepatology where appropriate.^[2][10] If you are concerned about your liver health, speak to your GP about whether assessment is indicated.

While the antioxidant and anti-inflammatory properties of bhumyamalaki's constituent compounds are biologically plausible mechanisms that could theoretically benefit liver health, plausibility alone does not confirm clinical benefit. The gap between laboratory findings and proven human outcomes is significant, and without large, well-designed randomised controlled trials specifically in people with MASLD, no reliable conclusions can be drawn about efficacy or optimal dosing.

If you are considering herbal remedies alongside conventional treatment, it is essential to be transparent with your healthcare team. Some people explore complementary approaches as part of a broader wellness strategy, and a GP or hepatologist can help you do so safely. For those seeking structured support for weight management, which is central to MASLD care, a range of evidence-based options exists, including dietary programmes, behavioural support and, where clinically appropriate, pharmacological treatment. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be considered.

If you experience symptoms such as persistent abdominal pain, yellowing of the skin or eyes, or unexplained fatigue, contact your GP promptly rather than self-treating with supplements.

Frequently Asked Questions